4//SEC Filing
Oliver Tracie 4
Accession 0001628280-23-024494
CIK 0000879407other
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 6:04 PM ET
Size
5.5 KB
Accession
0001628280-23-024494
Insider Transaction Report
Form 4
Oliver Tracie
Chief Commercial Officer
Transactions
- Sale
Common Stock
2023-07-03$35.31/sh−8,925$315,142→ 61,575 total
Footnotes (2)
- [F1]The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $34.95 to $35.94, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4.
- [F2]Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.
Documents
Issuer
ARROWHEAD PHARMACEUTICALS, INC.
CIK 0000879407
Entity typeother
Related Parties
1- filerCIK 0001935706
Filing Metadata
- Form type
- 4
- Filed
- Jul 5, 8:00 PM ET
- Accepted
- Jul 6, 6:04 PM ET
- Size
- 5.5 KB